Plasma Aldosterone Is Related to Severity of Obstructive Sleep Apnea in Subjects With Resistant Hypertension
The DOI matches its Crossref record; 38 of the 40 references it cites were found in a registry or an index.
Abstract
Objective Obstructive sleep apnea (OSA) and primary aldosteronism are common in subjects with resistant hypertension; it is unknown, however, if the two disorders are causally related. This study relates plasma aldosterone and renin levels to OSA severity in subjects with resistant hypertension, and in those with equally severe OSA but without resistant hypertension serving as control subjects. Methods Seventy-one consecutive subjects referred to the University of Alabama at Birmingham (UAB) for resistant hypertension (BP uncontrolled on three medications) and 29 control subjects referred to UAB Sleep Disorders Center for suspected OSA were prospectively evaluated by an early morning plasma aldosterone concentration (PAC) and renin level, and by overnight, attended polysomnography. Results OSA (apnea-hypopnea index [AHI] > or = 5/h) was present in 85% of subjects with resistant hypertension. In these subjects, PAC correlated with AHI (rho = 0.44, p = 0.0002) but not renin concentration. Median PAC was significantly lower in control subjects compared to subjects with resistant hypertension (5.5 ng/dL vs 11.0 ng/dL, p Conclusion OSA is extremely common in subjects with resistant hypertension. A significant correlation between PAC and OSA severity is observed in subjects with resistant hypertension but not in control subjects. While cause and effect cannot be inferred, the data suggest that aldosterone excess may contribute to OSA severity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Over 50% of subjects with resistant HTN have underlying OSA.698–700”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [699]
In the citing paper
“OSA is extremely common in patients with RH, with prevalence rates as high as 70% to 90%, and when present, OSA is often severe.272–277”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [277]
In the citing paper
“The high occurrence of OSA in patients with RH has been attributed to increased fluid retention and accompanying upper airway edema, as suggested by studies positively relating the presence and severity of OSA to aldosterone excess and high dietary sodium intake.47,49,277–279”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [277]
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Rechtschaffen, A. (1968) · Medical Entomology and Zoology · Cited by 12,654
Prospective Study of the Association between Sleep-Disordered Breathing and Hypertension
Peppard, P. E., Young, T., Palta, M., & Skatrud, J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005113421901 · Cited by 4,973
Marin, J. M., Carrizo, S. J., Vicente, E., & Agusti, A. G. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71141-7 · Cited by 4,678
Pickering, T. G., Hall, J. E., Appel, L. J., Falkner, B. E., Graves, J., Hill, M. N., Jones, D. W., Kurtz, T., Sheps, S. G., & Roccella, E. J. (2005) · Circulation · doi:10.1161/01.cir.0000154900.76284.f6 · Cited by 3,985
Using the Berlin Questionnaire To Identify Patients at Risk for the Sleep Apnea Syndrome
Netzer, N. C., Stoohs, R. A., Netzer, C. M., Clark, K., & Strohl, K. P. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-7-199910050-00002 · Cited by 2,973
Obstructive Sleep Apnea: Implications for Cardiac and Vascular Disease
Shamsuzzaman, A. S. M., Gersh, B. J., & Somers, V. K. (2003) · JAMA · doi:10.1001/jama.290.14.1906 · Cited by 1,188
High prevalence of unrecognized sleep apnoea in drug-resistant hypertension
Logan, A. G., Perlikowski, S. M., Mente, A., Tisler, A., Tkacova, R., Niroumand, M., Leung, R. S. T., & Bradley, T. D. (2001) · Journal of Hypertension · doi:10.1097/00004872-200112000-00022 · Cited by 960
Becker, H. F., Jerrentrup, A., Ploch, T., Grote, L., Penzel, T., Sullivan, C. E., & Peter, J. H. (2003) · Circulation · doi:10.1161/01.cir.0000042706.47107.7a · Cited by 931
Hyperaldosteronism Among Black and White Subjects With Resistant Hypertension
Calhoun, D. A., Nishizaka, M. K., Zaman, M. A., Thakkar, R. B., & Weissmann, P. (2002) · Hypertension · doi:10.1161/01.hyp.0000040261.30455.b6 · Cited by 763
Self-citation
Cited by
Items 201–300 of 357
Sleep Disorders in Chronic Kidney Disease
Brown, L. K., & Unruh, M. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815876-0.00036-x · Cited by 11
The Prevalence of Obstructive Sleep Apnea in Patients With Primary Aldosteronism
Sheu, J.-Y., Chang, L., Chen, J., Chuang, M., Wu, V., & Chueh, S. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae415 · Cited by 10
Hypertension in Cameroon associated with high likelihood of obstructive sleep apnea: a pilot study
NJAMNSHI, A. K., Mengnjo, M. K., Mbong, E. N., Kingué, S., Fonsah, J. Y., Njoh, A. A., Nfor, L. N., Ngarka, L., Chokote, S. E., & Ntone, F. E. (2017) · BMC Cardiovascular Disorders · doi:10.1186/s12872-017-0542-1 · Cited by 10
Han, S., Kim, H. J., & Lee, S. (2019) · Sleep And Breathing · doi:10.1007/s11325-019-01869-5 · Cited by 10
Zhang, J., Tian, L., & Guo, L. (2019) · Journal of International Medical Research · doi:10.1177/0300060519868337 · Cited by 11
Ghofrani, H., Weaver, F. A., & Nadim, M. K. (2014) · Cardiology Clinics · doi:10.1016/j.ccl.2014.09.003 · Cited by 11
Ruiz-Sánchez, J. G., Sánchez, Á. F., & Meneses, D. (2024) · Endocrine · doi:10.1007/s12020-024-03798-0 · Cited by 9
“PA itself entails a higher cardiovascular risk, and is strongly associated with other cardiovascular risk factors such as obesity [4 – 7], obstructive sleep apnea (OSA) [8 – 10], chronic kidney disease (CKD) [11, 12], metabolic syndrome, and type 2 diabetes (T2D) [13 – 16].”
Recent Advancements in the Treatment of Resistant Hypertension
Clark, D., Guichard, J. L., Calhoun, D. A., & Ahmed, M. I. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.01.2519 · Cited by 9
Self-citationYang, S.-J., Jiang, X.-T., Zhang, X., Yin, X., & Deng, W.-X. (2016) · Sleep And Breathing · doi:10.1007/s11325-015-1311-y · Cited by 9
Koo, P., Muntner, P., Hall, M. E., Gjelsvik, A., McCool, F. D., & Eaton, C. B. (2022) · American Journal of Hypertension · doi:10.1093/ajh/hpac091 · Cited by 9
Clinical approach in treatment of resistant hypertension
Frank, J., & Sommerfeld, D. (2009) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s4315 · Cited by 9
“com Dovepress one case control study(20) and has been reported to be present in the majority of patients with resistant hypertension presenting to a hypertension clinic.(21) Increased severity of OSA is associated with increased risk for resistant hypertension.”
Approach to Endocrine Hypertension: A Case-Based Discussion
Borozan, S., Kamrul-Hasan, A. B. M., Shetty, S., & Pappachan, J. M. (2025) · Current Hypertension Reports · doi:10.1007/s11906-025-01323-w · Cited by 8
“According to current knowledge, potential links include sympathetic overactivity, gut dysbiosis, and proinflammation [87], but also activation of RAAS and hyperaldosteronism [88, 89].”
Uncontrolled hypertension and obstructive sleep apnea: integrated treatment approach
Mikhailova, O. O., Gogiberidze, K. O., Elfimova, E. M., Litvin, A. Y., & Chazova, I. E. (2022) · Systemic Hypertension · doi:10.38109/2075-082x-2022-3-41-47 · Cited by 8
Hundemer, G. L., Imsirovic, H., Kendzerska, T., Vaidya, A., Leung, A. A. C., Kline, G. A., Goupil, R., Madore, F., Agharazii, M., Knoll, G. A., et al. (2023) · American Journal of Hypertension · doi:10.1093/ajh/hpad022 · Cited by 8
The pathogenesis of OSA-related hypertension: what are the determining factors?
Battaglia, E., Banfi, P. I., Compalati, E., Nicolini, A., de Terán, T. D., GONZALES, M., & Solidoro, P. (2023) · Minerva Medica · doi:10.23736/s0026-4806.23.08466-5 · Cited by 8
Evaluation and Pharmacologic Approach to Patients with Resistant Hypertension
Adams, M., Bellone, J. M., Wright, B. M., & Rutecki, G. W. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.01.2520 · Cited by 8
Frent, S., Tudorache, V., Ardelean, C. L., & Mihaicuta, S. D. (2014) · PubMed · Cited by 8
Primary Aldosteronism and Obstructive Sleep Apnea: A Cross-Sectional Multi-Ethnic Study
Wolf, J., & Narkiewicz, K. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13935 · Cited by 8
Splenic infarction associated with obstructive sleep apnoea/hypopnoea syndrome: a case report
Li, Y., Liu, H., & Shi, Y. (2020) · Journal of International Medical Research · doi:10.1177/0300060520954691 · Cited by 7
Obstructive Sleep Apnea and Hypertension: Is the Primary Link Simply Volume Overload?
Owen, J., & Reisin, E. (2013) · Current Hypertension Reports · doi:10.1007/s11906-013-0345-4 · Cited by 7
Current options for the treatment of resistant hypertension
Ahmed, M. I., Pisoni, R., & Calhoun, D. A. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.120 · Cited by 7
Self-citationApproaches for targeting blood pressure control in sleep disorders
Guralnick, A. S., & Bakris, G. L. (2012) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32835623f5 · Cited by 7
Marrone, O., Lombardi, C., & Parati, G. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32833f0e7e · Cited by 8
Obstructive Sleep Apnea and Hypertension
Cohen, D. L., & Townsend, R. R. (2013) · Journal of Clinical Hypertension · doi:10.1111/jch.12170 · Cited by 7
Armando Pérez, M., Aure, G., & Ruíz-Contreras, J. (2012) · Revista Venezolana de Endocrinología y Metabolismo · Cited by 7
Pitt, B. (2011) · Heart Failure Clinics · doi:10.1016/j.hfc.2011.11.001 · Cited by 6
Jugdutt, B. I. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0268-2_18 · Cited by 6
Overview of resistant hypertension: A glimpse of the cardiologist’s current standpoint
Paiva, L., Cachulo, M. C., Providencia, R., Barra, S., Dinis, P., & Leitao-Marques, A. (2012) · World Journal of Cardiology · doi:10.4330/wjc.v4.i9.275 · Cited by 6
Obstructive Sleep Apnea and Hypertension
Acosta, A. A. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-490-6_27 · Cited by 6
Circadian Biology in Obstructive Sleep Apnea-Associated Cardiovascular Disease
Gaspar, L. S., Pyakurel, S., Xu, N., D’Souza, S. P., & Koritala, B. S. C. (2025) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2025.03.008 · Cited by 5
Role of Sympathetic Nervous System in the Metabolic Syndrome and Sleep Apnea
Seravalle, G., & Grassi, G. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-420168-2.00018-1 · Cited by 5
Yang, J., Qiao, Y., Wu, L., & Wu, Z. (2024) · Obesity Surgery · doi:10.1007/s11695-023-07031-1 · Cited by 5
Shamsuzzaman, A., Szczesniak, R. D., Fenchel, M. C., & Amin, R. S. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2014.05.022 · Cited by 6
Deng, G., Qiu, Z., Li, D., Fang, Y., & Zhang, S. (2016) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-016-1636-1 · Cited by 5
Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet?
Prosser, H. C. G., Gregory, C., Hering, D., Hillis, G. S., Perry, G. J., Rosman, J. B., Schultz, C. J., Thomas, M., Watts, G. F., & Schlaich, M. P. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0728-z · Cited by 5
Neuroglobin correlates with cryptochrome-1 in obstructive sleep apnea with primary aldosteronism
Tedjasukmana, R., Purba, J. S., Wanandi, S. I., & Suyatna, F. D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204390 · Cited by 5
Apnéia Obstrutiva do Sono e Arritmias Cardíacas: Apnéia Obstrutiva do Sono e Arritmias Cardíacas
Wiggert, G. T., de Faria, D. G., Castanho, L. A. D. R., Dias, P. A. C., & Greco, O. T. (2010) · Journal of Cardiac Arrhythmias · Cited by 6
Objawy, powikłania i leczenie obturacyjnego bezdechu sennego
Szymańska, J., & Dobrowolska-Zarzycka, M. (2013) · Medycyna Ogólna i Nauki o Zdrowiu · Cited by 5
Case Detection Testing for Primary Aldosteronism in Male Patients with Hypertension and Snoring
Zhang, N. L. Y. (2014) · Journal of Hypertension Open Access · doi:10.4172/2167-1095.1000180 · Cited by 4
Dysfonction cardiaque et syndrome d’apnée du sommeil
Bocquillon, V., Destors, M., Guzun, R., Doutreleau, S., Pépin, J., & Tamisier, R. (2019) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2019.07.011 · Cited by 4
Implications of Renal Denervation Therapy in Patients with Sleep Apnea
Jaén-Águila, F., Vargas‐Hitos, J. A., & Mediavilla-García, J. D. (2015) · International Journal of Hypertension · doi:10.1155/2015/408574 · Cited by 5
Sołtysiak, M., Miazgowski, T., Jaroszyńska, E., Janowska, A., & Widecka, K. (2015) · Arterial Hypertension · doi:10.5603/ah.2015.0003 · Cited by 4
Resistant Hypertension: Core Curriculum 2008
Parker, M. G. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.11.040 · Cited by 4
Resistant Hypertension and Untreated Severe Sleep Apnea: Slowly Gaining Insight
Harding, S. M. (2014) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.3948 · Cited by 4
Self-citationHypertension: From Epidemiology to Therapeutics
Velasco, M., & Israili, Z. H. (2012) · International Journal of Hypertension · doi:10.1155/2012/908431 · Cited by 3
Champ‐Rigot, L., Ferchaud, V., Prévost, J.-N., Moirot, P., Pellissier, A., Legallois, D., Alexandre, J., Scanu, P., Morello, R., Saloux, É., et al. (2018) · Clinical Medicine Insights Cardiology · doi:10.1177/1179546817751628 · Cited by 3
Li, X., Heizhati, M., Li, M., Yao, L., Wu, T., Yang, W., Gan, L., Wang, H., Liu, M., Maitituersun, A., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-91538-3 · Cited by 3
Sleeping Beauty or the Beast? – The Metabolic Syndrome from an Obstructive Sleep Apnoea Perspective
Tarnow, L., Klinkenbijl, B., Woehrle, H., & Market Development Manager Diabetes and Sleep Apnoea Europe, R. (2010) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2013.09.01.12 · Cited by 3
Possible mechanisms of drug-resistance in hypertensive patients with obstructive sleep apnea
Звартау, Н. Э., Sviryaev, Y. V., Коростовцева, Л. С., & Конради, А. О. (2012) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2012-18-3-184-190 · Cited by 3
Sleep-time predictors of cardiovascular complications in surgical peripheral arterial disease
Utriainen, K. T. (2019) · UTUPub (University of Turku) · Cited by 3
Syndrome Z and Its Association with Obstructive Sleep Apnea
Hassan, G. (2018) · International Journal of Diabetes and Endocrinology · doi:10.11648/j.ijde.20180301.13 · Cited by 2
Primary aldosteronism and resistant arterial hypertension
Звартау, Н. Э., Коростовцева, Л. С., Emelyanov, I. V., & Sviryaev, Y. V. (2012) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2012-18-6-514-521 · Cited by 2
Options for patients with out-of-control blood pressure: after all avenues have been exhausted
Zeng, W., & Tomlinson, B. (2024) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2024.2401875 · Cited by 2
“OSA is commonly associated with resistant hypertension, possibly because they share common underlying mechanisms such as aldosterone excess [28].”
Brachmann, J., Schnupp, S., & Blüm, B. (2012) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2012.06.009 · Cited by 2
Costa, Y. S., Lim, A. S. P., Thorpe, K. E., Mitchell, S., Masellis, M., Lam, B. Y. B., Black, S., & Boulos, M. I. (2022) · Sleep Medicine · doi:10.1016/j.sleep.2022.05.396 · Cited by 2
Cardiac function and hypertension in patients with obstructive sleep apnea
Gonzaga, C. C., Bertolami, A., & Amodeo, C. (2014) · Research Reports in Clinical Cardiology · doi:10.2147/rrcc.s52232 · Cited by 3
“cant prevalence of aldosteronism can be observed, that reaches 28%.(20,67,68) In individuals with resistant hyperten-”
Hipertensión arterial resistente o refractaria
Alonso, J. (2012) · Revista Uruguaya de Cardiología · Cited by 2
Primary aldosteronism (Conn's syndrome)
Ceccato, F., Tizianel, I., Voltan, G., & Mantero, F. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-96120-2.00014-5 · Cited by 2
Gruber, B., Benning, L., Bousraou, Z., Somaini, D., & Schwarz, E. I. (2026) · European Respiratory Review · doi:10.1183/16000617.0192-2026 · Cited by 1
“Recurrent intermittent hypoxia promotes persistent sympathetic activation and stimulates the RAAS, contributing to vasoconstriction, sodium retention and myocardial and vascular remodelling [14, 30, 33, 34].”
Syndrome d’apnées obstructives du sommeil et hypertension artérielle réfractaire
Baguet, J. P., & Barone‐Rochette, G. (2008) · Archives des Maladies du Coeur et des Vaisseaux - Pratique · doi:10.1016/s1261-694x(08)74610-8 · Cited by 1
Primary Aldosteronism: Progress in Diagnosis, Therapy, and Genetics
Mulatero, P., Williams, T. A., Monticone, S., Viola, A., Tizzani, D., Crudo, V. L., Burrello, J., & Veglio, F. (2012) · Humana Press eBooks · doi:10.1007/978-1-60761-548-4_1 · Cited by 1
The use of positive airway pressure therapy for treatment of resistant hypertension
Won, C. H. J., & Guilleminault, C. (2016) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2016.1132626 · Cited by 1
“Hyperaldosteronism has also been proposed as a mechanism by which OSA and rHTN interact [26].”
BackgroundSoh, L. M. (2018) · Springer eBooks · doi:10.1007/978-981-10-1124-5_27 · Cited by 1
Questionnaire-assessed risk of sleep apnea in inpatients with various endocrine disorders
Мисникова, И. В., Kovaleva, Y. A., Gubkina, V. A., & Klimina, N. A. (2019) · Almanac of Clinical Medicine · doi:10.18786/2072-0505-2019-47-023 · Cited by 1
Sleep Disorders in Chronic Kidney Disease
Roumelioti, M., Strollo, P. J., & Unruh, M. L. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0987-2.00014-5 · Cited by 1
Majewski, C., & Bakris, G. L. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_5-2 · Cited by 1
Obturacyjny bezdech senny jako intedyscyplinarny problem medyczny
Wysocki, J., Prus, M., & Balcerzak, J. (2014) · Polski Przegląd Otorynolaryngologiczny · doi:10.1016/j.ppotor.2014.02.004 · Cited by 1
Lackland, D. T. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2013.851002 · Cited by 1
Obstrüktif uyku apne sendromu ve iskemik inme
Üzüner, N., & Üzüner, N. (2013) · Turkish Journal of Cerebrovascular Diseases · doi:10.5505/tbdhd.2013.93924 · Cited by 1
Obstructive sleep apnea and hypertension: Interactions and clinical implications
Kapa, S., Gami, A. S., & Somers, V. K. (2011) · Informa Healthcare eBooks · doi:10.3109/9781420020885.011 · Cited by 2
Resistant hypertension: Definition, evaluation, and new therapeutic approaches to treatment
Rosa, M. L. D. (2017) · Diseases and Disorders · doi:10.15761/jdd.1000101 · Cited by 1
“Recent studies suggest that adding spironolactone or eplerenone to existing antihypertensive regimens for patients with resistant hypertension who are obese or have sleep apnea provides significant BP reduction [11,73].”
BackgroundThe Relationship between Obesity, Insulin Resistance and Aldosterone Levels
Mazzuco, T. L. (2018) · Current Research in Diabetes & Obesity Journal · doi:10.19080/crdoj.2018.06.555680 · Cited by 1
Leary, E. B., Zinchuk, A. V., Stone, K. L., & Mehra, R. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202003-0586up · Cited by 1
Association Between Plasma Aldosterone and Sleep Apneas in Arterial Hypertension
Schiavone, M. J., Nosetto, D., Ernst, G., Saravia, M. A., Salvado, A., Avaca, H. A., & Borsini, E. E. (2020) · Revista Argentina de Cardiología · doi:10.7775/rac.v88.i4.17720 · Cited by 1
Connecting the Dots: Heart Failure and Insomnia
Kapica, M., Momot, K., Żmijewska, A., Sztybór, M., Krzyžanowska, M., Maleszewska, M., Piątkiewicz, J., Nowak, G., Wojtas, M., & Głogowska, K. (2024) · Journal of Education Health and Sport · doi:10.12775/jehs.2024.62.013 · Cited by 1
da Rocha, A. F., Rocha, A. C. D. A. S. D. C., Gomes, É. S., Tepedino, G. T., Teixeira, G. B., Oliveira, G. C. F., Carneiro, L. G., Calleri, N. T. B., & Rangel, F. A. D. A. (2024) · EPITAYA eBooks · doi:10.47879/ed.ep.2024479p171 · Cited by 1
Lombardi, C., Mariani, D., & Parati, G. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000108 · Cited by 1
Hypertension and obstructive sleep apnoea
Wolf, J., & Narkiewicz, K. (2009) · Cited by 1
Gavrilović, B. (2016) · TSpace (University of Toronto) · Cited by 1
Manolis, A. J. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734299250.793571584 · Cited by 1
Analyse der Salzsensitivität im intravenösen Salzbelastungstest
Engelkamp, C. (2018) · Dokumentenrepositorium der RUB (Ruhr University Bochum) · Cited by 1
Koç, A. (2015) · DSpace - Düzce (Duzce University) · Cited by 1
Pimenta, E. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.98.2012.tde-07122012-113447
Fitscha, P., & Haoula, D. (2014) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 1
Schlaf & arterielle Hypertonie
Sanner, B. M. (2014) · Schlaf · doi:10.1055/s-0038-1626082
“Inwieweit der bei Patienten mit obstruktiver Schlafapnoe und therapieresistenter Hypertonie dokumentierte Hyperaldosteronismus hierbei bedeutsam ist (15) und Aldosteronantagonisten therapeutisch für beide Erkrankungen wirksam sind, muss aktuell noch offen blei-”
Diabetes and Hypertension in People with Sleep Apnea: Risk Evaluation and Therapeutic Rationale
Pandey, A. K., Olafiranye, O., Adedayo, M., Zizi, F., McFarlane, S. I., & Jean‐Louis, G. (2012) · Humana Press eBooks · doi:10.1007/978-1-60327-357-2_5
Obstructive Sleep Apnea in Cardiovascular Disease - Mechanisms and Impact of Treatment
Thunström, E. Ö. (2015) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Neues zu Aldosteron und dem Mineralokortikoidrezeptor
Fiebeler, A. (2007) · Der Nephrologe · doi:10.1007/s11560-007-0119-6
Approach to the true resistant hypertensive and treatment approaches
Weir, M. (2015) · Journal of Indian College of Cardiology · doi:10.1016/j.jicc.2015.03.020
Obstructive Sleep Apnea and Hypertension
Ahmed, S., & Shapiro, J. I. (2016)
Nicholl, D. D. M. (2012) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/27159
Progression in Diagnosis and Treatment of Resistant Hypertension
He, M., Mu, J. J., Fuqiang, L. I. U., Ren, K., Yang, W. A. N. G., & 郭统帅 (2014) · Journal of Cardiovascular Medicine and Cardiology · doi:10.17352/2455-2976.000001
Treatment Strategies for Resistant Arterial
Himmel, F., Ukena, C., & Schunkert, H. (2011)
Acosta, A. A. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-824-9_25
Effet du Valsartan sur 3 marqueurs inflammatoires chez le sujet SAOS : comparaison à la CPAP
Béhouche, A. (2013) · OpenGrey (Institut de l'Information Scientifique et Technique)
Nadra, M. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique)
Obstructive sleep apnea and arterial hypertension
Pascale, C., Pinna, G., & Artom, N. (2016) · Italian Journal of Medicine · doi:10.4081/itjm.2016.692
GRITTI, A. (2010) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/gritti-anna_phd2010-12-17
Metadata
- Authors
- Pratt-Ubunama, M. N., Nishizaka, M. K., Boedefeld, R. L., Cofield, S. S., Harding, S. M., & Calhoun, D. A.
- Affiliations
- University of Alabama at Birmingham (US)
- Corresponding author
- Calhoun, David A.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2007-02
- Volume
- 131
- Issue
- 2
- Pages
- 453-459
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2119080429
- Semantic Scholar
- ce0dd68286168a857920d1b2f90f2b9a608a19c0
- Cited by
- 331
- References
- 40
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 12 · 2023: 9 · 2022: 14 · 2021: 8 · 2020: 16 · 2019: 22 · 2018: 18 · 2017: 18 · 2016: 21 · 2015: 20 · 2014: 35 · 2013: 20 · 2012: 28
- FWCI
- 13.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- CHEST Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Pharmacology (medical) › Apelin-related biomedical research
- Keywords
- obstructive sleep apnea, resistant hypertension, plasma aldosterone, renin, apnea-hypopnea index, OSA severity, primary aldosteronism, sex differences, aldosterone excess
- MeSH terms
- Adult, Aged, Aldosterone, Female, Humans, Hypertension, Male, Middle Aged, Prospective Studies, Respiratory Function Tests, Severity of Illness Index, Case-Control Studies, Polysomnography, Sleep Apnea, Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.